Rcpharm SRL
The score of Rcpharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +76 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rcpharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 03 Nov 2023
- Year ended 31 Dec 2021filed on 18 Oct 2022
Rcpharm's financial analysis
- Solvency45.6%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rcpharm
Rcpharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.235.182
- VAT number
- BE0829235182
- Peppol
- Registered · 0208:0829235182 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Sep 2010
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Rcpharm (SRL) has been based in Woluwe-Saint-Pierre since 2010, active in: activities of holding companies. For 2025, it reports a net profit of 245,245 € and equity of 997,212 €; its revenue is not published. Its solvency stands at 45.6%, below the median of its sector (60.1%).
Companies similar to Rcpharm
Companies in the same business, of comparable size and area, outside its group.
- Hanne VNF Activities of holding companies Olen · balance sheet €2.19m
- Goupie Activities of holding companies Sombreffe · balance sheet €2.19m
- Bagaza Activities of holding companies Celles (lez-Tournai) · balance sheet €2.19m
- Myfin Activities of holding companies Assenede · balance sheet €2.18m
- EMEL Activities of holding companies Balen · balance sheet €2.19m
- LP Build & Invest Activities of holding companies Geetbets · balance sheet €2.19m
- Verso-Invest Activities of holding companies Deinze · balance sheet €2.19m
- Pastil Activities of holding companies Erpe-Mere · balance sheet €2.19m
Frequently asked questions about Rcpharm
What is the revenue of Rcpharm?
Rcpharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rcpharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0829235182 for Rcpharm, if the company is VAT-registered. Its company number (CBE) is 0829.235.182.
Where is the registered office of Rcpharm?
According to the CBE register, the registered office of Rcpharm is in 1150 Woluwe-Saint-Pierre.
What is the equity of Rcpharm?
At the close of the 2025 financial year, the equity of Rcpharm amounts to 997,212 €, a solvency of 45.6% of total assets.
Who manages Rcpharm?
The register lists 2 active mandates at Rcpharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rcpharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →